News

Advanced chemistry techniques reveal thousands of sites on immune proteins where drug molecules may be able to bind, opening new possibilities for treating immune-driven conditions.

Scripps Research is collaborating with frontline workers at the San Diego Metropolitan Transit System and Scripps Health to help detect and track viral illnesses in near real-time.

The compound hits a vulnerable spot on multiple strains of the flu, attacking the virus in a whole new way.

The $25,000 award will support scientific research in organic chemistry, with a view to enabling drug discovery.

Scientists reveal a new role for cells that already are known to be implicated in many other brain-based diseases, including Alzheimer’s and Huntington’s.

A new study reveals how two key neural circuits dictate the choice between social approach and avoidance.  The findings will enable researchers to evaluate social interventions in autism.

Findings of the new study support many vaccine strategies currently being used to tackle the new coronavirus.

The award will support Erb’s drug discovery platform to identify novel cancer therapies.

Blackmond joins a long line of respected scholars defined as being “Nunquam otiosus,” or “never idle,” the motto of the academy.

The program helps prepare and support talented new investigators at pivotal moments in their career.

Huntington’s disease progression involves a promoter of inflammation and autophagy, the cellular housekeeping process, a new study finds.  

The Board of Overseers, one of two governing boards at Scripps Research, provides expertise and leadership to advance the institute’s mission.

The rich data stored in electronic medical records may offer clues to better care for those diagnosed with coronavirus disease.

Some common strains of influenza are able to mutate to evade some of the broad-acting antibodies that could be elicited by a universal flu vaccine. 

With an initial focus on screening local healthcare workers and first responders, the study seeks to understand the prevalence of coronavirus infections in the community.

Promoting a healthy gut microbiome may be a powerful strategy for lowering cholesterol and other heart attack risk factors.

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against the coronavirus that causes the disease.

Cravatt is recognized for major technical advances in activity-based protein profiling, which is used to find potential new targets and drug candidates for cancer treatment.

A tiny genetic mutation to the virus that causes COVID-19 leads to a significant change in the virus’ ability to infect cells, according to new research from Hyeryun Choe, PhD, and Michael Farzan, PhD.

Scripps Research is collaborating with top computational scientists at Johns Hopkins University and UCLA.

On behalf of the institute, the leadership team at Scripps Research voices its recommitment to expanding diversity and inclusion across its campuses.

Analysis of data from 16 groups of COVID-19 patients suggest “silent” carriers may exacerbate efforts to stop spread of the disease

Scientists discovered a way to enhance the activity of an enzyme long suspected of playing a role in metabolism. In a study involving mice, the compound reversed signs of diabetes.